Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.5 USD | +5.74% | +4.79% | -18.98% |
Financials (USD)
Sales 2024 * | 104M | Sales 2025 * | 119M | Capitalization | 173M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 11M | EV / Sales 2024 * | 1.67 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.46 x |
P/E ratio 2024 * |
-331
x | P/E ratio 2025 * |
16.1
x | Employees | 157 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.06% |
Latest transcript on Alimera Sciences, Inc.
1 day | -8.82% | ||
1 week | -3.78% | ||
Current month | -15.13% | ||
1 month | -17.04% | ||
3 months | -14.91% | ||
6 months | +5.75% | ||
Current year | -23.38% |
Managers | Title | Age | Since |
---|---|---|---|
David Holland
FOU | Founder | 60 | 03-06-03 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Pizzo
BRD | Director/Board Member | 57 | 10-03-31 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3.5 | +5.74% | 11 275 |
24-04-25 | 3.31 | -8.82% | 25,225 |
24-04-24 | 3.63 | +1.11% | 7,722 |
24-04-23 | 3.59 | +1.41% | 16,176 |
24-04-22 | 3.54 | +5.99% | 25,959 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.38% | 173M | |
-4.66% | 87.53B | |
+2.63% | 40.42B | |
-21.76% | 29.48B | |
+55.83% | 25.43B | |
-14.78% | 15.59B | |
-18.49% | 11.49B | |
-15.61% | 11.1B | |
-44.02% | 11.3B | |
+4.72% | 8.75B |
- Stock Market
- Equities
- ALIM Stock